| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 56,332 | 37,958 | 1,235 | 653 | | Cost of Revenue | 8,252 | 9,419 | 8,774 | 9,801 | | | Gross Profit | 48,080 | 28,539 | (7,539) | (9,148) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,557 | 15,422 | 17,797 | 42,702 | | Non Recurring |
-
|
-
|
-
| (147) | | Others | 14,269 | 12,795 | 12,062 | 11,509 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,254 | 322 | (37,398) | (63,212) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,396 | 46,560 | 3,309 | 4,942 | | Earnings Before Interest And Taxes | (25,713) | 46,882 | (34,089) | (58,270) | | Interest Expense | 61,557 | 61,959 | 53,250 | 52,597 | | Income Before Tax | (87,270) | (15,077) | (87,339) | (110,867) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (590) | 2,027 | 4,597 | 4,083 | | | | Net Income From Continuing Ops | 2,866 | (13,050) | (82,742) | (106,784) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (42,497) | (13,050) | (82,742) | (106,784) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($42,497) | ($13,050) | ($82,742) | ($106,784) |
|
0.51% Nasdaq 
Income Statement
